Medications

Repurposed drug shows promise for treating cardiac arrhythmias

Ruxolitinib, a drug that is already approved by the U.S. Food and Drug Administration (FDA) for treating certain cancers and skin conditions, is effective at inhibiting CaMKII, a protein kinase linked to cardiac arrhythmias.

Neuroscience

Brain games reveal clues about how the mind works

Scientists are using supercomputers and data from the game Ebb and Flow to train deep learning models that mimic the human behavior of "task-switching," shifting attention from one task to another.

Neuroscience

Why green light helps reduce pain in mice

A team of researchers at Fudan University's, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institutes of Brain Science, in China, has traced neural activity from the eyes to the ...

Oncology & Cancer

Photodynamic therapy offers promise for cancer treatment

While chemotherapy drugs can be lifesaving, they don't work for all patients or for all cancers. But a team of UTM researchers is looking at new ways to use special types of light to target cancer cells resistant to current ...

page 3 from 40